New scan could reveal hidden inflammation in Sjögren's patients

NCT ID NCT07062523

Recruiting now Diagnosis Sponsor: Peking Union Medical College Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a special PET scan that uses a radioactive tracer called 68Ga-FAPI to see inflammation in people with Sjögren's syndrome, an autoimmune disease that causes dryness. Researchers will compare the scan results with standard blood tests and also look at scans from cancer patients to see differences. The goal is to find a better way to measure disease activity and guide treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: 68Ga-FAPI (a radioactive tracer for PET imaging)
What this could lead to: If successful, this could provide a new way to see and measure inflammation in Sjögren's syndrome, helping doctors choose the right treatments.
What could go wrong: This is an early-phase study with only 60 participants, so results may not apply to everyone. The imaging method is still experimental and not yet proven to improve outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SJOGREN'S SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neoplasm Sjogren syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SJOGREN'S SYNDROME

Contacts and locations

Locations

Peking Union Medical College Hospital
RECRUITING

Beijing, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.